Melanoma Survivors Encourage Others to Protect Their Skin

An expert explained the importance of patient choice in treatment decisions for high-risk, resectable melanoma, based on their own treatment goals.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

An expert explains how gene-expression profile testing can inform treatment decisions for patients with squamous cell carcinoma.

From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.

A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.